BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36336867)

  • 1. Perspectives on the Use of Toxicogenomics to Assess Environmental Risk.
    Portugal J; Mansilla S; Piña B
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):294. PubMed ID: 36336867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
    Youns M; Hoheisel JD; Efferth T
    Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET; Zira AN; Theocharis SE
    J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in "omics" technologies for toxicological research].
    Inadera H; Uchida M; Shimomura A
    Nihon Eiseigaku Zasshi; 2007 Jan; 62(1):18-31. PubMed ID: 17334089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA; Bruno ME
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
    Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicogenomics in drug development.
    Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
    Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomics and systems toxicology: aims and prospects.
    Waters MD; Fostel JM
    Nat Rev Genet; 2004 Dec; 5(12):936-48. PubMed ID: 15573125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
    Currie RA; Orphanides G; Moggs JG
    Reprod Toxicol; 2005; 20(3):433-40. PubMed ID: 15964738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drivers of and Obstacles to the Adoption of Toxicogenomics for Chemical Risk Assessment: Insights from Social Science Perspectives.
    Pain G; Hickey G; Mondou M; Crump D; Hecker M; Basu N; Maguire S
    Environ Health Perspect; 2020 Oct; 128(10):105002. PubMed ID: 33112659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxicogenomics as a tool for evaluation of chemical effects].
    Watanabe H
    Yakugaku Zasshi; 2007 Dec; 127(12):1967-74. PubMed ID: 18057786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomic profiling of chemically exposed humans in risk assessment.
    McHale CM; Zhang L; Hubbard AE; Smith MT
    Mutat Res; 2010 Dec; 705(3):172-83. PubMed ID: 20382258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver.
    Pandiri AR; Auerbach SS; Stevens JL; Blomme EAG
    Toxicol Pathol; 2023 Oct; 51(7-8):470-481. PubMed ID: 38288963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects and challenges of multi-omics data integration in toxicology.
    Canzler S; Schor J; Busch W; Schubert K; Rolle-Kampczyk UE; Seitz H; Kamp H; von Bergen M; Buesen R; Hackermüller J
    Arch Toxicol; 2020 Feb; 94(2):371-388. PubMed ID: 32034435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics using yeast DNA microarrays.
    Yasokawa D; Iwahashi H
    J Biosci Bioeng; 2010 Nov; 110(5):511-22. PubMed ID: 20624688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of genomics in model in vitro systems.
    Casciano DA
    Adv Exp Med Biol; 2012; 745():210-20. PubMed ID: 22437820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.